Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$367K Buy
2,968
+450
+18% +$48.4K ﹤0.01% 1439
2026
Q1
$258K Buy
+2,518
New +$257K ﹤0.01% 1485
2025
Q3
$396K Buy
+4,581
New +$362K ﹤0.01% 963

Other funds holding NUVL

CIBC Bancorp USA's NUVL Position: Q2 2026 in Review

CIBC Bancorp USA increased its Nuvalent (NUVL) stake by 18% in Q2 2026, buying an estimated $48.4K and bringing the position to 2,968 shares worth $367K. The position accounts for ﹤0.01% of the portfolio, ranked #1439.

CIBC Bancorp USA first reported a position in NUVL in Q3 2025 and has held it in 3 quarters since. The position peaked at $396K in Q3 2025. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • CIBC Bancorp USA held 2,968 shares of Nuvalent worth $367K as of Q2 2026.
  • CIBC Bancorp USA bought 450 Nuvalent shares in Q2 2026, an estimated $48.4K.
  • Nuvalent made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1439 holding.
  • CIBC Bancorp USA first reported a position in Nuvalent in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Nuvalent position peaked at $396K in Q3 2025.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.